Year-end figures paint 2004 as a strong year, with biotech raising about $20.8 billion, a 26 percent increase to the $16.5 billion mark of 2003. The year also saw an increase in IPOs and several key product approvals.

That data and more are revealed in the BioWorld Biotechnology State of the Industry Report 2005. Compiled and published by the editors of BioWorld Today, the 428-page report contains information on every facet of the industry: new product development, biotech stock performance, corporate deals and scientific breakthroughs.

"This report is a comprehensive review of the biotech industry throughout the year," said Managing Editor Brady Huggett. "All the important aspects of a robust 2004 are included."

For more information, call 1-800-688-2421 or 1-404-262-5476.